Functional coupling of capping and transcription of mRNA

Molecular Cell

Volumn 10, Issue 3, 2002, Pages 599-609

  Moteki, Shin ^a   Price, David ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CTD KINASE KIN28; CYCLIN DEPENDENT KINASE 9; MESSENGER RNA; PHOSPHOTRANSFERASE; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; CAPPING PHENOMENON; CHEMICAL REACTION; GUANYLYLATION; HUMAN; METHYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DOMAIN; RNA TRANSCRIPTION; TRANSCRIPTION INITIATION;

EID: 0036753427     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00660-3     Document Type: Article

References (42)

1. Bentley D. The mRNA assembly line. transcription and processing machines in the same factory Curr. Opin. Cell Biol. 14:2002;336-342.
2. Bochnig P., Reuter R., Bringmann P., Luhrmann R. A monoclonal antibody against 2,2,7-trimethylguanosine that reacts with intact, class U, small nuclear ribonucleoproteins as well as with 7- methylguanosine-capped RNAs. Eur. J. Biochem. 168:1987;461-467.
3. Cho E.J., Takagi T., Moore C.R., Buratowski S. mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 11:1997;3319-3326.
4. Cho E.J., Rodriguez C.R., Takagi T., Buratowski S. Allosteric interactions between capping enzyme subunits and the RNA polymerase II carboxy-terminal domain. Genes Dev. 12:1998;3482-3487.
5. Coppola J.A., Field A.S., Luse D.S. Promoter-proximal pausing by RNA polymerase II in vitro. transcripts shorter than 20 nucleotides are not capped Proc. Natl. Acad. Sci. USA. 80:1983;1251-1255.
6. Cramer P., Srebrow A., Kadener S., Werbajh S., de la Mata M., Melen G., Nogues G., Kornblihtt A.R. Coordination between transcription and pre-mRNA processing. FEBS Lett. 498:2001;179-182.
7. Easton J., Kidd V.J. Analysis of the 5′ flanking sequences from the human protein kinase p58 (PITSLRE beta 1)-encoding gene. Gene. 145:1994;279-282.
8. Fong N., Bentley D.L. Capping, splicing, and 3′ processing are independently stimulated by RNA polymerase II. different functions for different segments of the CTD Genes Dev. 15:2001;1783-1795.
9. Hagler J., Shuman S. A freeze-frame view of eukaryotic transcription during elongation and capping of nascent mRNA. Science. 255:1992;983-986.
10. Ho C.K., Shuman S. Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol. Cell. 3:1999;405-411.
11. Ho C.K., Sriskanda V., McCracken S., Bentley D., Schwer B., Shuman S. The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 273:1998;9577-9585.
12. Komarnitsky P., Cho E.J., Buratowski S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14:2000;2452-2460.
13. Luo Y., Hagler J., Shuman S. Discrete functional stages of vaccinia virus early transcription during a single round of RNA synthesis in vitro. J. Biol. Chem. 266:1991;13303-13310.
14. Mao X., Shuman S. Vaccinia virus mRNA (guanine-7-)methyltransferase. mutational effects on cap methylation and AdoHcy-dependent photo-cross-linking of the cap to the methyl acceptor site Biochemistry. 35:1996;6900-6910.
15. Marshall N.F., Price D.H. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12:1992;2078-2090.
16. Marshall N.F., Price D.H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:1995;12335-12338.
17. Marshall N.F., Peng J., Xie Z., Price D.H. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:1996;27176-27183.
18. McCracken S., Fong N., Rosonina E., Yankulov K., Brothers G., Siderovski D., Hessel A., Foster S., Shuman S., Bentley D.L. 5′-capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997;3306-3318.
19. Meininghaus M., Chapman R.D., Horndasch M., Eick D. Conditional expression of RNA polymerase II in mammalian cells. Deletion of the carboxyl-terminal domain of the large subunit affects early steps in transcription. J. Biol. Chem. 275:2000;24375-24382.
20. Pei Y., Shuman S. Interactions between fission yeast mRNA capping enzymes and elongation factor Spt5. J. Biol. Chem. 277:2002;19639-19648.
21. Peng J., Liu M., Marion J., Zhu Y., Price D.H. RNA polymerase II elongation control. Cold Spring Harb. Symp. Quant. Biol. 63:1998;365-370. a.
22. Peng J., Marshall N.F., Price D.H. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J. Biol. Chem. 273:1998;13855-13860. b.
23. Peng J., Zhu Y., Milton J.T., Price D.H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762. c.
24. Pillutla R.C., Yue Z., Maldonado E., Shatkin A.J. Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA polymerase IIo complexes. J. Biol. Chem. 273:1998;21443-21446.
25. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634.
26. Proudfoot N. Connecting transcription to messenger RNA processing. Trends Biochem. Sci. 25:2000;290-293.
27. Proudfoot N.J., Furger A., Dye M.J. Integrating mRNA processing with transcription. Cell. 108:2002;501-512.
28. Rasmussen E.B., Lis J.T. In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes. Proc. Natl. Acad. Sci. USA. 90:1993;7923-7927.
29. Renner D.B., Yamaguchi Y., Wada T., Handa H., Price D.H. A highly purified RNA polymerase II elongation control system. J. Biol. Chem. 276:2001;42601-42609.
30. Rodriguez C.R., Cho E.J., Keogh M.C., Moore C.L., Greenleaf A.L., Buratowski S. Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol. Cell. Biol. 20:2000;104-112.
31. Schroeder S.C., Schwer B., Shuman S., Bentley D. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 14:2000;2435-2440.
32. Shatkin A.J. Capping of eucaryotic mRNAs. Cell. 9:1976;645-653.
33. Shatkin A.J., Manley J.L. The ends of the affair. capping and polyadenylation Nat. Struct. Biol. 7:2000;838-842.
34. Shim E.Y., Walker A.K., Shi Y., Blackwell T.K. CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes Dev. 16:2002;2135-2146.
35. Shuman S. Capping enzyme in eukaryotic mRNA synthesis. Prog. Nucleic Acid Res. Mol. Biol. 50:1995;101-129.
36. Shuman S. Structure, mechanism, and evolution of the mRNA capping apparatus. Prog. Nucleic Acid Res. Mol. Biol. 66:2001;1-40.
37. Shuman S., Broyles S.S., Moss B. Purification and characterization of a transcription termination factor from vaccinia virions. J. Biol. Chem. 262:1987;12372-12380.
38. Takase Y., Takagi T., Komarnitsky P.B., Buratowski S. The essential interaction between yeast mRNA capping enzyme subunits is not required for triphosphatase function in vivo. Mol. Cell. Biol. 20:2000;9307-9316.
39. Wada T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S., Sugimoto S., Yano K., Hartzog G.A., Winston F.et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12:1998;343-356.
40. Wen Y., Shatkin A.J. Transcription elongation factor hSPT5 stimulates mRNA capping. Genes Dev. 13:1999;1774-1779.
41. Yue Z., Maldonado E., Pillutla R., Cho H., Reinberg D., Shatkin A.J. Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc. Natl. Acad. Sci. USA. 94:1997;12898-12903.
42. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M.B., Price D.H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.